TLR2 Expression in Peripheral CD4+ T Cells Promotes Th17 Response and Is Associated with Disease Aggravation of Hepatitis B Virus-Related Acute-On-Chronic Liver Failure-Reference-Cited by-同舟云学术

TLR2 Expression in Peripheral CD4+ T Cells Promotes Th17 Response and Is Associated with Disease Aggravation of Hepatitis B Virus-Related Acute-On-Chronic Liver Failure

Published:2017-11-23 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Xu Chunli,Lu Yinping,Zheng Xin,Feng Xuemei,Yang Xuecheng,Timm Joerg,Wu Jun,Wang Baoju,Lu Mengji,Yang Dongliang,Liu Jia

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference51 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

2. Hepatitis B virus infection – natural history and clinical consequences;Ganem;N Engl J Med,2004

3. Expression of toll-like receptor 9 in peripheral blood mononuclear cells from patients with different hepatitis B and C viral loads;Zhou;J Huazhong Univ Sci Technolog Med Sci,2009

4. Prediction of survival for patients with fulminant hepatic failure;Neuberger;Hepatology,2005

5. Acute-on chronic liver failure;Jalan;J Hepatol,2012

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orchestrated regulation of immune inflammation with cell therapy in pediatric acute liver injury;Frontiers in Immunology;2023-06-22

2. Downregulated VISTA enhances Th17 differentiation and aggravates inflammation in patients with acute-on-chronic liver failure;Hepatology International;2023-03-22

3. Contribution of T- and B-cell intrinsic toll-like receptors to the adaptive immune response in viral infectious diseases;Cellular and Molecular Life Sciences;2022-10-12

4. Current Advances of Innate and Adaptive Immunity in Acute-on-Chronic Hepatitis B Liver Failure;Infectious Diseases & Immunity;2022-03-10

5. Novel Molecular Therapeutics Targeting Signaling Pathway to Control Hepatitis B Viral Infection;Frontiers in Cellular and Infection Microbiology;2022-02-18